Volume 20

Issue 3

Article 13

2012

Ineffectiveness of cholic acid and cyprinol sulfate on the toxicity
of streptozotocin in rats

Follow this and additional works at: https://www.jfda-online.com/journal

Recommended Citation
Hwang, D.-F.; Yeh, Y.-H.; and Hsieh, Y.-L. (2012) "Ineffectiveness of cholic acid and cyprinol sulfate on the
toxicity of streptozotocin in rats," Journal of Food and Drug Analysis: Vol. 20 : Iss. 3 , Article 13.
Available at: https://doi.org/10.6227/jfda.2012200309

This Original Article is brought to you for free and open access by Journal of Food and Drug Analysis. It has been
accepted for inclusion in Journal of Food and Drug Analysis by an authorized editor of Journal of Food and Drug
Analysis.

628
Journal of Food and Drug Analysis, Vol. 20, No. 3, 2012, Pages 628-636

doi:10.6227/jfda.2012200309

Ineffectiveness of Cholic Acid and Cyprinol Sulfate on the
Toxicity of Streptozotocin in Rats
DENG-FWU HWANG1, YEN-HUNG YEH2,3* AND YOU-LIANG HSIEH4
1.

2.

Department of Food Science, National Taiwan Ocean University, Keelung, Taiwan, R.O.C.
School of Health Diet and Industry Management, Chung Shan Medical University, Taichung, Taiwan, R.O.C.
3.

Department of Nutrition, Chung Shan Medical University Hospital, Taichung, Taiwan, R.O.C.

4.

Department of Health and Nutrition Biotechnology, Asia University, Taichung, Taiwan, R.O.C.
(Received: September 20, 2011; Accepted: March 20, 2012)

ABSTRACT
The possible effects of bile acid and bile alcohol on the visual acuity of streptozotocin (STZ)-induced hyperglycemia male Wistar
rats were investigated. Forty-eight rats were divided into two groups, STZ and non-STZ, and intraperitoneally injected with STZ (60 mg/
kg body weight in 0.6 mL of saline) and saline (0.6 mL) on day 1, respectively. After 4 days of STZ treatment, all the rats were tested for
glycosuria and then divided into four groups. Each group had 6 rats and the rats were treated orally every 3 days with saline and the nontoxic dosages of cholic acid (37 mg/kg) and cholic acid (74 mg/kg) combined with cyprinol sulfate (37 mg/kg). At the end of the 29-day
experiment, the results revealed that the relative ratios of liver and kidney weight to body weight, the concentrations of RBC, hemoglobin
and hematocrit in the blood, as well as the levels of AST, ALT, ALP, BUN and creatinine in the plasma of the rats were not significantly
different. However, the levels of plasma glucose and liver thiobarbituric acid-relative substances (TBARS) in the rats treated with STZ
were higher, while the levels of vitamin A in the cornea were contrarily lower than those of the non-STZ rats. The values of three indicators
(plasma glucose, liver TBARS and vitamin A) related to visual acuity were not significantly influenced when the rats were treated with
cholic acid alone or combined with cyprinol sulfate in the STZ or non-STZ group. The results indicated that both cholic acid and cyprinol
sulfate could not influence the toxicity of STZ in rats.
Key words: cholic acid, cyprinol sulfate, bile acid, streptozotocin, toxicity

INTRODUCTION
In traditional Chinese medicine, the gallbladder is
an important crude drug, which includes the bile of bears,
cows, grass carps (ctenopharyngodon idellus), common
carps (cyprinus carpio), snakes and chickens. The bile is
thought to induce antitussive and hypotensive actions and
enhance visual acuity. However, a survey of toxic fish in
China by Ng and Kum(1) showed that the number of cases
of food poisoning from the ingestion of fish gallbladders is
only second to eating pufferfish. Fresh-water fish are bred
in many areas of the world as a another source of food is a
concern for people eating fish gallbladders. The extraction of
toxic substances from grass carp bile has been performed(2-5)
and it is generally agreed that poisoning occurs through the
action of a group of bile alcohols or acids found in the bile
of this family of fish(6). There have been many studies on the
* Author for correspondence. Tel: +886-4-24730022;
Fax: +886-4-3248188; E-mail: yhyeh@csmu.edu.tw

structures and pharmacological effects of bile and gallstone
components, especially the bile of bear and snake, in which
C-24 bile acids such as cholic acid and chenodeoxycholic
acid are major components(7). In contrast, less work has
been done on the chemical elucidation of bile alcohol, such
as cyprinol, which is a major component of the Cyprinidae
family(6,8). The major component by weight (> 94%) in the
bile of common carps and grass carps was cyprinol sulfate,
while cholic acid, chenodeoxycholic acid and lithocholic acid
accounted for less than 5%(9,13). It has been reported that the
ingestion of bile juices, especially carp bile juice, causes
severe toxic effects in humans(3). In some severe cases,
the ingestion of raw carp bile causes death of experimental
animals, due to a decrease in blood pressure and an increase
in plasma potassium, hydrogen ions, blood urea nitrogen
and hematocrit(14). The toxin in carp bile is identified as
5α-cyprinol sulfate (5α-cholestane-3α, 7α, 12α, 26, 27-pentol
26 [or 27]-sulfate), an alcohol specific to carp bile(10).
Cyprinol sulfate is suggested to be the causative agent of
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common carp bile toxicity(9,10). The bile from various fishes,
such as sharks, carps, mackerels and crucians, has also been
used as a crude drug to treat dyspnea due to disorders of the
throat and pharynx and eye disease, among others, and as
an analgesic(1). The animal gallbladder is considered a bittercold medicine that enters the liver, gallbladder, spleen and
stomach channels to detoxify and clear heat. It is used for
delirium, extensive burns, high fever and convulsions. Topically, it alleviates skin pain and is used for reducing swelling
and trauma caused by sprains and fractures(11).
To our knowledge, no pharmacological study for the
visual acuity of these compounds has been reported yet.
During our toxicological studies on the bile alcohol of grass
carp and bile acids of laboratory animals, it is of great interest
to study the pharmacological use of bile acid and bile alcohol
in the improvement of visual acuity. It has been reported that
the visual acuity of diabetic rats could be induced by streptozotocin (STZ)(12-15). Diabetes mellitus is one of the endocrine
disorders characterized by hyperglycemia complications
affecting the eyes. The underlying mechanism of diabetic
complications remains unclear, though possible events such
as the activation of oxidative stress have been suggested(16-22).
In recent years, much attention has been focused on the role of
oxidative stress and it has been suggested that oxidative stress
may constitute the key and common event in the pathogenesis
of different diabetic complications(22). In fact, increasing the
generation of reactive oxygen intermediates (ROS) such as
superoxide anion, hydroxyl anion and peroxynitrite anion has
been shown to occur in diabetes in association with hyperglycemia(23). Therefore, the aim of this study was to examine
if there is protective function of bile acid and bile alcohol on
visual acuity using STZ induced hyperglycemic rat model.
In a previous report(14), 148 mg/kg each of cholic acid and
cyprinol sulfate was found to be toxic on the liver and kidney
in rats. In this study, the protective effect of bile alcohol and
bile acid in the safe dosage range of 37 to 74 mg/kg was investigated on visual acuity in STZ-induced hyperglycemia rats.

MATERIALS AND METHODS
I. Preparation of Carp Bile Powder and Chemicals
About 10 L of fresh gall bladders of the grass carp
(Ctenopharyngodon idellus) was collected from Taoyuan
County. The bile juices were filtered and freeze-dried. The
grass carp bile powder (1,500 g) was stored at -18°C before
use. Cholic acid and STZ (98%) were obtained from Sigma
(St. Louis, MO, USA). All other chemicals used in this study
are of analytical grade.
II. Animals
Male Wistar rats, 4 weeks old, were purchased from the
National Laboratory Animal Center and housed individually in
stainless steel wire bottom cages in a controlled environment
(25oC, 50-60% humidity, 12 h of light per day) for 2 weeks.

The animals were fed a laboratory diet (Laboratory Rodent
Diet 5001; PMI Feeds, Richmond, VA, USA). The weight of
rats were 270 ± 10 g at the start of the experiment. Tap water
was supplied in free access. This study was approved by the
Institutional Animal Care and Use Committee (IACUC No.
940) of Chung Shan Medical University.
III. Cyprinol Sulfate from the Grass Carp Bile Powder
A portion (20 g) of grass carp bile powder was extracted
thrice with 60 mL of ethanol. The combined extract was
defatted with dichloromethane and evaporated to dryness. The
residue was extracted thrice with distilled water/n-butanol
(1 : 1). The n-butanol layer was collected and evaporated to
dryness. The n-butanol extract was dissolved with methanol
and applied onto a PHP-LH 20 and silica gel column (20 ×
2 cm) according to the method of Hwang et al.(24). The purified grass carp bile salt (7.6 g) was dissolved and crystallized
in acetonitrile. The crystal was evaporated to dryness. The
crystallized 5α-cyprinol sulfate was kept in a desiccator and
stored in a cold room before use(14,25-27).
IV. Animal Test
Forty-eight male Wistar rats were fasted for 12 h before
the start of the experiment. The rats were then divided into two
groups, STZ and non-STZ. In the STZ group, the rats were
treated with STZ (60 mg/kg in 0.6 mL saline solution with 10
mM of citrate buffer, pH = 4.5, i.p.). The urine was collected
and urine glucose was tested by using Ames reagent strips
(Sanko Co. Ltd., Tokyo, Japan) after 4 days. In the non-STZ
group, the rats treated with the same amount of saline solution. On day 5, the rats in each group were selected based on
the urine glucose of 263 mg/dL and then divided into four
groups. Each group had 6 rats and the rats were treated orally
for every 3-day treatment with 0.6 mL saline solution (control
group), 37 mg/kg body weight of cholic acid, 74 mg/kg body
weight of cholic acid and 37 mg/kg body weight of cyprinol
sulfate in 0.6 mL of saline, respectively. The concentrations of
cholic acid (10 mg), cholic acid (20 mg) and cyprinol sulfate
(10 mg) were 0.024 × 10-6 M, 0.049 × 10-6 M and 0.019 ×
10-6 M, respectively. On days of 5 and 17, blood was obtained
by tail vein puncture after 6 h of administration. On day 29,
the rats were weighed and anesthetized with diethyl ether.
Blood was obtained by heart puncture with syringes. The
conical cornea, liver and kidney of rats were quickly excised.
A part of liver and conical cornea was stored at -20oC for
thiobarbituric-reactive substances (TBARS), vitamin A and
retinol-binding-protein (RBP) determination.
The blood was analyzed using a CELL DYN 500
Hematology Analyzer (Sequoia-Turner, USA) to determine
the levels of red blood cells (RBC), hematocrit, white blood
cells (WBC) and hemoglobin (Hb). Plasma was collected by
the centrifugation (1,000 g × 15 min) of blood and analyzed
using a Merck VITALAB Selectra Biochemical Autoanalyzer
(Merck, Germany) to determine the levels of glucose, blood
urea nitrogen (BUN), creatinine, aspartate aminotransferase

630
Journal of Food and Drug Analysis, Vol. 20, No. 3, 2012

(AST), alanine aminotransferase (ALT) and alkaline phosphatase (ALP). The levels of vitamin A and retinol-bindingprotein (RBP) in the plasma were also determined.
V. TBARS Production
Lipid peroxidation activities in the liver were assayed
by the measurement of malondialdehyde (MDA), an endproduct of peroxidized fatty acids, and thiobarbituric acid
(TBA) reaction product. The sample of 20% liver homogenate was mixed with 1.0 mL of 0.4% TBA in 0.2 N HCl and
0.15 mL of 0.2% BHT in 95% ethanol. The samples were
then incubated in a 90°C water-bath for 45 min. After incubation, the TBAMDA adduct was extracted with isobutanol.
The isobutanol extract was mixed with methanol (2 : 1) prior
to injection into the HPLC system(28). The supernatant was
examined by using the HPLC system at an excitation wavelength of 515 nm and an emission wavelength of 550 nm on
a Hitachi Fluorescence Detector (Tokyo, Japan).

glutathione disulfide (GSSG) and 2-nitro-5-thiobenzoic acid
(TNB). GSSG was then reduced enzymatically by NADPH
and glutathione reductase (GR) to regenerate GSH. Concentrations of DNTB, NADPH and GR were chosen such that
the rate of the overall reaction was linearly proportional to
the concentration of total glutathione. The rate of formation
of TNB was followed spectrophotometrically, and assay was
calibrated using a standard solution of TNB. If the sample
was reacted with 2-vinylpyridine, GSH was derivatized, and
only GSSG was detected during subsequent assay(33).
IX. Statistical Analysis
A two-tailed Student’s t-Test(34) was used to determine if
the two population means were equal. A common application
of this test is to determine if a new process or treatment is
superior to a current process or treatment. A p value of less
than 0.05 was considered statistically significant.

RESULTS

VI. Measurement of Vitamin A Level
About 0.l g (mL) of sample (conical cornea, plasma and
liver) was extracted thrice with chloroform/methanol solvent
(2 : 1, v/v) in a dark room. The extracts were combined
and evaporated to remove the organic solvents. Then an
equal volume of 25% KOH in methanol solution containing
1,000 ppm each of vitamin C and BHT was added and heated
in a 80°C water-bath for 30 min. After soap treatment, diethyl
ether/petroleum ether (1 : 1, v/v) was added to the extract. The
extract was evaporated by nitrogen gas and the residue was
dissolved with 1 mL of hexane/isopropanol (95 : 5, v/v)(29).
The solution was examined for vitamin A level at a wavelength of 325 nm by using HPLC (Hitachi, Tokyo, Japan).
VII. Measurement of Retinol-Binding-Protein (RBP) Level
Each tissue sample (plasma and liver) was homogenized
in 9 volumes of PBS (pH 7.5) containing 0.5% Triton X-100,
2.5 mM of EDTA and 1 mM of phenylmethylsulfonyl fluoride using a Polytron homogenizer for 60 s and sonicated for
15 s according to the method of Sparks et al.(30). After the
homogenates were centrifuged at 105,000 ×g for 1 h (4°C),
the clear supernatant fraction (cytosol) was frozen at -20°C
and used for the assay of RBP. RBP was purified to a fluorescence spectral and immunological homogeneity from the
plasma of 3-month-old Sprague-Dawley rats as described by
McGuire and Chytil(31), and monospecific IgG polyclonal
rabbit anti-rat RBP anti-serum was prepared. RBP was quantified by sandwich-type enzyme-linked immunosorbent assay
(ELISA, ALPCO Diagnostics, Salem, NH, USA) according
to the procedure reported by Goda et al.(32)

After STZ treatment, all the rats were tested positive for
glycosuria (263 mg/dL)(48). The effect of STZ on the glucose
level in the plasma of rats is shown in Table 1. The glucose
level in the plasma of rats increased significantly when
the rats were treated with STZ. After the 29-day treatment
with cholic acid and cyprinol sulfate, glucose levels did not
decrease significantly. The results indicated that STZ could
induce diabetic rats, and cholic acid and cyprinol sulfate did
not reduce the symptoms of diabetes. The effects of cholic
acid and cyprinol sulfate on the levels of vitamin A in the
conical cornea, plasma and liver of rats treated with and
without STZ are shown in Table 2. After the 29-day treatment
with bile salt, the levels of vitamin A in the conical cornea,
plasma and liver of rats treated without STZ were about 70
ng/g, 1.25 ng/mL and 430 ng/g, respectively. In comparison,
Table 1. Effects of bile salts on plasma glucose levels (mg/dL) of rats
treated with or without streptozotocin after 29 days1
Control
Treatment Day (0.6 mL
of saline)

37

Cyprinol sulfate
(37 mg/kg in
0.6 mL of saline)

74

Without streptozotocin
5

89 ± 15a 88 ± 22a 88 ± 23a

88 ± 23a

17

87 ± 23a 86 ± 17a 88 ± 28a

87 ± 20a

29

87 ± 21

a

a

87 ± 21

a

87 ± 23

88 ± 24a

With streptozotocin
264 ± 25b 278 ± 33b 262 ± 32b

268 ± 33b

17 263 ± 31b 258 ± 28b 275 ± 28b

258 ± 25b

5

VIII. Measurement of Glutathione (GSH) Levels
Glutathione (GSH) reacted non-enzymatically
with 5,5’dithiobis (2-nitrobenzoic acid)(DTNB) to yield

Cholic acid
(mg/kg in 0.6 mL
of saline)

b

b

b

29 265 ± 24 257 ± 24 254 ± 33
1

257 ± 26b

Data represents mean ± S.D. (n = 6). The values in the same row
are not significantly different, while those in the same column with
different superscripts (a - b) are significantly different (p < 0.05).
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the vitamin A levels for the rats were treated with STZ were
lower, at about 20 ng/g, 0.5 ng/mL and 310 ng/g, respectively.
The results indicated that STZ induced glycosuria and visual
damage in the rats, but cholic acid and cyprinol sulfate did
not influence the STZ-induced toxicity in rats. The effects
of cholic acid and cyprinol sulfate on the body weight and
ratios of kidney and liver weights to body weight are shown
in Table 3. After the 29-day treatment, the body weight and
the ratios of kidney and liver weights to body weight of rats in
the STZ and non-STZ groups were not affected by any dose
of cholic acid and cyprinol sulfate treatments.
In biochemistry, the activities of AST, ALT and ALP in
plasma are generally tested as indicators for liver functions,
and the levels of creatinine and BUN in the plasma are tested
as indicators for kidney function(35-37). The effects of cholic
acid and cyprinol sulfate on the BUN and creatinine levels
and AST, ALT and ALP activities in the plasma of rats are
shown in Tables 4 and 5. On the interval days of 5, 17 and
29, BUN and creatinine levels and the activities of AST, ALT
and ALP in the plasma of rats were not significantly changed.

Hence, 74 mg/kg of cholic acid, 37 mg/kg of cyprinol sulfate,
and STZ were found to have no harmful effect on the functions of liver and kidney. In a previous report(25), 148 mg/kg
of cholic acid and cyprinol sulfate was known to be toxic. In
addition, the effects of cholic acid and cyprinol sulfate on the
RBC, WBC, hematocrit and hemoglobin levels in blood in
the rats treated with or without STZ were not found during
the 29-day experimental period (data not shown). These data
supported the above results that less than 74 mg/kg of cholic
acid and less than 37 mg/kg of cyprinol sulfate did not have
any adverse effect on the liver and kidney of rats.
The effects of cholic acid and cyprinol sulfate on the
RBP of plasma and liver in the rats after the 29-day experimental period are shown in Table 6. It was found that STZ
and bile salts (cholic acid and cyprinol sulfate) did not affect
the concentration of RBP in the plasma and liver. However,
STZ significantly increased the TBARS level, but not the
GSH level in the liver of rats (Table 7). In addition, cholic
acid and cyprinol sulfate did not influence the liver oxidation
caused by STZ.

Table 2. Effects of bile salts on vitamin A levels in the conical cornea (ng/g), plasma (ng/mL) and liver (ng/g) of rats treated with or without
streptozotocin after 29 days1
Treatment

Control
(0.6 mL of saline)

Cholic acid
(mg/kg in 0.6 mL of saline)

Cyprinol sulfate
(37 mg/kg in 0.6 mL of saline)

74

37
In the conical cornea
Without streptozotocin

a

62.1 ± 5.1a

66.3 ± 4.4a

65.5 ± 3.3a

b

b

b

22.2 ± 1.8

22.1 ± 1.5b

69.6 ± 4.2

With streptozotocin

22.4 ± 1.4

20.1 ± 1.9

Without streptozotocin

1.25 ± 0.02a

1.23 ± 0.03a

1.24 ± 0.04a

1.23 ± 0.02a

With streptozotocin

0.53 ± 0.03b

0.54 ± 0.02b

0.55 ± 0.02b

0.54 ± 0.03b
420 ± 52a

In the plasma

In the liver
Without streptozotocin

a

427 ± 49a

430 ± 50a

b

b

b

422 ± 53

With streptozotocin
312 ± 38
316 ± 41
313 ± 38
316 ± 37b
1
Data represents mean ± S.D. (n = 6). The values in the same row are not significantly different, while those in the same column with different
superscripts (a - b) are significantly different (p < 0.05).
Table 3. Effects of bile salts on body weight and the ratios of kidney and liver weight to body weight of rats treated with or without streptozotocin after 29 days1
Treatment

Control
(0.6 mL of saline)

Cholic acid
(mg/kg in 0.6 mL of saline)
37

74

Cyprinol sulfate
(37 mg/kg in 0.6 mL
of saline)

Without streptozotocin
Body weight (g)

260 ± 19

264 ± 22

274 ± 21

273 ± 22

Ratios of kidney weights to body weight (%)

0.54 ± 0.03

0.54 ± 0.03

0.57 ± 0.04

0.54 ± 0.05

2.2 ± 0.3

2.2 ± 0.4

2.1 ± 0.3

2.4 ± 0.3

Body weight (g)

271 ± 19

265 ± 21

265 ± 20

272 ± 20

Ratios of kidney weights to body weight (%)

0.52 ± 0.04

0.52 ± 0.03

0.51 ± 0.04

0.53 ± 0.05

2.3 ± 0.2

2.4 ± 0.4

2.5 ± 0.3

2.1 ± 0.4

Ratios of liver weights to body weight (%)
With streptozotocin

Ratios of liver weights to body weight (%)
1

Data represents mean ± S.D. (n = 6). The values in the same row and column are not significantly different (p > 0.05).
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Table 4. Effects of cholic acid and cyprinol sulfate on the levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT) and alkaline phosphatase (ALP) in the plasma of rats treated with or without streptozotocin after 29 days1
Treatment

Day

Control
(0.6 mL of saline)

Cholic acid
(mg/kg in 0.6 mL of saline)
37

Cyprinol sulfate
(37 mg/kg in 0.6 mL of saline)

74

For AST (U/L)
Without streptozotocin

With streptozotocin

5

124 ± 22

115 ± 13

120 ± 15

118 ± 19

17

121 ± 20

121 ± 17

124 ± 14

120 ± 15

29

127 ± 22

125 ± 16

121 ± 17

125 ± 18

5

124 ± 23

119 ± 17

123 ± 25

124 ± 16

17

122 ± 18

127 ± 15

128 ± 19

123 ± 18

29

119 ± 19

123 ± 14

124 ± 16

124 ± 17

5

36 ± 12

39 ± 14

39 ± 15

39 ± 13

17

38 ± 13

34 ± 13

36 ± 15

36 ± 17

29

36 ± 14

36 ± 117

39 ± 16

41 ± 21

For ALT (U/L)
Without streptozotocin

With streptozotocin

5

35 ± 16

35 ± 22

34 ± 19

37 ± 23

17

35 ± 20

37 ± 20

23 ± 24

37 ± 25

29

37 ± 18

34 ± 19

39 ± 19

38 ± 17

For ALP (U/L)
Without streptozotocin

With streptozotocin

1

5

269 ± 22

269 ± 21

273 ± 15

264 ± 19

17

267 ± 21

271 ± 17

273 ± 16

271 ± 16

29

277 ± 26

271 ± 16

278 ± 18

269 ± 14

5

264 ± 23

264 ± 24

353 ± 27

255 ± 21

17

251 ± 24

282 ± 26

261 ± 12

267 ± 18

29

261 ± 23

274 ± 27

262 ± 24

260 ± 18

Data represents mean ± S.D. (n = 6). The values in the same row and column are not significantly different (p > 0.05).

Table 5. Effects of bile salts on the levels of blood urea nitrogen (BUN) and creatinine in the plasma of rats treated with or without streptozotocin after 29 days1
Treatment

Day

Control
(0.6 mL of saline)

Cholic acid
(mg/kg in 0.6 mL of saline)
37

Cyprinol sulfate
(37 mg/kg in 0.6 mL of saline)

74

BUN (mg/dL)
Without streptozotocin

With streptozotocin

5

13.1 ± 1.3

13.1 ± 1.4

12.4 ± 1.4

12.4 ± 1.5

17

12.6 ± 1.2

12.5 ± 1.2

12.2 ± 1.5

12.6 ± 1.7

29

12.7 ± 1.5

12.9 ± 1.4

12.5 ± 1.3

12.8 ± 1.6

5

12.8 ± 1.4

12.4 ± 1.6

13.4 ± 1.4

12.7 ± 1.7

17

12.5 ± 1.7

13.1 ± 1.3

12.6 ± 1.4

13.2 ± 1.6

29

12.4 ± 1.6

12.7 ± 1.5

12.4 ± 1.6

12.6 ± 1.8

5

0.41 ± 0.04

0.39 ± 0.04

0.38 ± 0.04

0.40 ± 0.02

17

0.39 ± 0.04

0.38 ± 0.03

0.40 ± 0.03

0.40 ± 0.03

29

0.41 ± 0.03

0.40 ± 0.03

0.39 ± 0.04

0.41 ± 0.03

Creatinine (mg/dL)
Without streptozotocin

With streptozotocin

1

5

0.40 ± 0.03

0.37 ± 0.03

0.39 ± 0.04

0.40 ± 0.03

17

0.42 ± 0.03

0.40 ± 0.03

0.42 ± 0.03

0.41 ± 0.03

29

0.40 ± 0.03

0.39 ± 0.03

0.41 ± 0.02

0.39 ± 0.03

Data represents mean ± S.D. (n = 6). The values in the same row and column are not significantly different (p > 0.05).
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Table 6. Effects of bile salts on the levels of retinol binding protein (RBP) in the plasma and liver of rats treated with or without streptozotocin
after 29 days1
Treatment

Day

Control
(0.6 mL of saline)

Cholic acid
(mg/kg in 0.6 mL of saline)
37

Cyprinol sulfate
(37 mg/kg in 0.6 mL of saline)

74

Plasma (μg/mL)
Without streptozotocin

5

a

22.6 ± 3.3a

23.5 ± 3.2a

23.5 ± 3.5a

a

a

a

23.3 ± 3.2

17

25.1 ± 3.6

23.5 ± 3.2

23.2 ± 3.5

23.6 ± 3.3a

29

24.7 ± 3.3a

23.9 ± 3.1a

23.6 ± 3.3a

23.8 ± 3.6a

5

b

13.5 ± 3.5

b

13.2 ± 3.6

b

13.3 ± 3.5

13.7 ± 3.7b

17

13.1 ± 3.7b

13.6 ± 3.3b

12.7 ± 3.3b

13.5 ± 3.6b

29

b

13.3 ± 3.6

b

b

12.8 ± 3.6

13.6 ± 3.8b

Without streptozotocin

29

41.3 ± 8.5a

42.3 ± 8.3a

42.5 ± 8.6a

43.5 ± 8.2a

With streptozotocin

29

25.5 ± 4.7b

25.2 ± 4.9b

25.3 ± 4.5b

24.3 ± 4.7b

With streptozotocin

13.7 ± 3.5

Liver tissue (μg/g)

1

Data represents mean ± S.D. (n = 6). The values in the same row are not significantly different, while those in the same column with different
superscripts (a - b) are significantly different (p < 0.05).

Table 7. Effects of bile salts on the levels of thiobarbituric acid-reactive substances (TBARS) and glutathione (GSH) in the liver of rats treated
with or without streptozotocin after 29 days1
Treatment

Control
(0.6 mL of saline)

Cholic acid
(mg/kg in 0.6 mL of saline)
37

Cyprinol sulfate
(37 mg/kg in 0.6 mL of saline)

74

TBARS (nmol/g wet liver)
Without streptozotocin

22.3 ± 1.4a

22.7 ± 1.7a

21.1 ± 1.5a

22.2 ± 1.2a

With streptozotocin

32.5 ± 1.6b

30.8 ± 1.2b

31.2 ± 1.4b

30.2 ± 1.4b

24.8 ± 1.7

24.3 ± 1.4

GSH (nmol/g wet liver)
Without streptozotocin

24.7 ± 2.1

26.5 ± 1.5

With streptozotocin
25.4 ± 1.7
25.7 ± 1.8
24.4 ± 1.5
25.1 ± 1.7
1
Data represents mean ± S.D. (n = 6). The values in the same row are not significantly different, while those in the same column with different
superscripts (a - b) are significantly different (p < 0.05).

DISCUSSION
Renal failure, liver dysfunction and cardiovascular
and gastrointestinal impairment are featured as the common
symptoms of poisoning by grass carp bile juice(38-40). In a
previous study, rats administered with 0.6 mL of grass carp
bile juice were also intoxicated and displayed renal failure
and liver dysfunction. For this reason, rats could be used as
an animal model to evaluate the safe dosage of grass carp
bile juice(14).
Diabetes mellitus (DM) is a metabolic disease characterized by inadequate production or utilization of insulin.
It is the major cause of retinopathy leading to blindness
in adults(41). Prolonged vitamin A deficiency can lead to
night blindness due to impaired production of rhodopsin,
the compound in the retina responsible for detecting small
amounts of light. Xerophthalmia, a condition characterized
by changes to the conjunctiva and cornea of the eye, also
results from prolonged vitamin A deficiency and is a major

cause of blindness in developing nations(42). Despite this
common clinical consequence of vitamin A deficiency and
DM, it is only very recently that some significant studies have
been carried out linking the two conditions.
Streptozotocin (STZ)-induced diabetic rats have been
associated with a decrease in plasma and an increase in
hepatic vitamin A concentrations compared to nondiabetic
animals(13-15,48). It was of interest that the diabetic animals
had lower plasma concentrations of retinol despite its
increased food intake by 50%. A decrease in the concentration of 11-cis-retinal, a constituent of rhodopsin in the retina
of the eye was also reported in parallel with a decrease in
circulatory level of retinol in diabetic rats(49-51).
Recent studies have shown that plasma concentration
of vitamin A (retinol) and its carrier proteins, retinol-binding
protein (RBP) and transthyretin (TTR) are decreased in
human subjects with insulin-dependent diabetes mellitus
(IDDM)(44-47). Rats made diabetic with STZ have also been
shown to have reduced levels of plasma vitamin A(12,13,15).
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The decreases in plasma retinol, RBP and TTR concentrations
were a response to diabetes(12,13,15,52). Then, the increase of
free oxidative products is suggested to cause eye damage(5356)
. As the vitamin A levels in the conical cornea, plasma and
liver of rats were significantly reduced, rats with eye damage
could be induced by STZ (60 mg/kg, i.p.) in this study. After
the STZ treatment, the glucose test was all positive in the urine
of rats. The levels of glucose in the plasma of rats treated with
STZ were also found to be higher than those of rats treated
without STZ. Other indicators, including the activities of
AST, ALT and ALP in the plasma (liver functional indicators), the concentrations of BUN and creatinine in the plasma
(kidney functional indicators), as well as the blood and histological characteristics of liver and kidney were found to be
not affected by STZ. After the 29-day experimental period,
similar results were obtained the STZ and non-STZ group
rats. The results indicated that 74 mg/kg of cholic acid and
37 mg/kg cyprinol sulfate did not have an adverse effect on
liver and kidney functions. Furthermore, vitamin A levels
in the conical cornea, plasma and liver, TBARS level in the
liver, and glucose level in the plasma were not affected in the
STZ and non-STZ groups when the rats were treated with
or without cholic acid and cyprinol sulfate. Cholic acid and
cyprinol sulfate did not induce toxicity in mild diabetic rats.
Eye damage can be induced by STZ due to a decrease
in the levels of plasma vitamin A, RBP and TTR(12,13,15,5256,65)
. Eye damage in diabetic rats could be induced by STZ,
followed by the assessment of the protective effects of treatment with bile alcohol and bile acid on the eye. The results
suggested the protective effect of bile salts on visual acuity, as
there was no enhancement of visual damage induced by STZ.
Cholic acid and cyprinol sulfate did not alter STZ-induced
vitamin A levels in the conical cornea, plasma and liver.
Meanwhile, cholic acid and cyprinol sulfate did not influence
hepatic lipid peroxidation and glucose level in the plasma of
rats. Hence, cholic acid and cyprinol sulfate have no effect
on the toxicity of STZ in rats. The results of this study did
not support the use of bile salts as a medicinal material for
curing STZ-induced damage. Further study on other medicinal functions is required. The animal bile juice had been
proven to be effective on special diseases. For example, there
were some evidence that bear bile juice could cure various
cholestatic disorders(66-67). However, due to the occasional
poisoning cases from the consumption of animal bile juices, it
is suggested that consumers should not consume animal bile
juices or believe in their medicinal effects.
Until now, animal gallbladders are believed by Asians
to have a medicinal action on the enhancement of visual
acuity. However, from the results obtained in this study, the
ameliorating effect of cholic acid and cyprinol sulfate on
STZ-induced visual damage was not found. Moreover, oxidative stress in liver and glycosuria in the rats induced by STZ
were also not affected by cholic acid and cyprinol sulfate.
Hence, bile acids and alcohols could not influence the toxicity
of STZ in rats.
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